Our data suggest that the CD44+ CRC has its place among the common rare cell population as a separate cell entity which is supported by the finding of the respective phenotype in 8 out of 10 healthy individuals measuring a median 1.5 cells per 5 mL. The gene discussed is CD44; the disease is colorectal carcinoma.